Position
Parallel Advisors, LLC in Ptc Therapeutics, Inc.
Back to the book · All holders of PTCT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$297$75.95 → $68.14
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 38 | $2.89K | — | — | — | 0.0% |
| Q1 2026 | 43 | $2.93K | $68.14 | −$297 | $341 | 0.0% |